Literature DB >> 15764734

sigma Receptor activation blocks potassium channels and depresses neuroexcitability in rat intracardiac neurons.

Hongling Zhang1, Javier Cuevas.   

Abstract

The sigma receptors have been implicated in the regulation of the cardiovascular system, and sigma-1 receptor transcripts have been found in parasympathetic intracardiac neurons. However, the cellular function of sigma-1 receptors in these cells remains to be determined. Effects of sigma receptor activation on voltage-activated K(+) channels and action potential firing were studied in isolated intracardiac neurons using whole-cell patch-clamp recording techniques. Activation of sigma receptors reversibly blocked delayed outwardly rectifying potassium channels, large conductance Ca(2+)-sensitive K(+) channels, and the M-current with maximal inhibition >80%. The inhibition of K(+) channels by sigma ligands was dose-dependent, and the rank order potency of (+)-pentazocine > ibogaine > 1,3-di-O-tolyguanidin (DTG) suggests that the effect is mediated by sigma-1 receptor activation. Preincubation of neurons with the irreversible sigma receptor antagonist metaphit blocked DTG-induced inhibition of K(+) channels, confirming that the effect is mediated by sigma receptor activation. Although bath application of sigma ligands depolarized intracardiac neurons, the number of action potentials fired by the cells in response to depolarizing current pulses was decreased in the presence of these drugs. Neither dialysis of the neurons nor application of intracellular 5'-O-(2-thiodiphosphate) trilithium salt inhibited the effect of sigma receptors on K(+) channels, which suggests that the signal transduction pathway does not involve a diffusible cytosolic second messenger or a G protein. Together, these data suggest that sigma-1 receptors are directly coupled to K(+) channels in intracardiac neurons. Furthermore, activation of sigma-1 receptors depresses the excitability of intracardiac neurons and is thus likely to block parasympathetic input to the heart.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15764734     DOI: 10.1124/jpet.105.084152

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  33 in total

1.  Demonstration of a direct interaction between sigma-1 receptors and acid-sensing ion channels.

Authors:  Stewart M Carnally; Molly Johannessen; Robert M Henderson; Meyer B Jackson; J Michael Edwardson
Journal:  Biophys J       Date:  2010-04-07       Impact factor: 4.033

2.  The sigma-1 receptor chaperone as an inter-organelle signaling modulator.

Authors:  Tsung-Ping Su; Teruo Hayashi; Tangui Maurice; Shilpa Buch; Arnold E Ruoho
Journal:  Trends Pharmacol Sci       Date:  2010-10-01       Impact factor: 14.819

Review 3.  PRE-084 as a tool to uncover potential therapeutic applications for selective sigma-1 receptor activation.

Authors:  Zeinab Y Motawe; Salma S Abdelmaboud; Javier Cuevas; Jerome W Breslin
Journal:  Int J Biochem Cell Biol       Date:  2020-07-12       Impact factor: 5.085

4.  Trace amines depress D(2)-autoreceptor-mediated responses on midbrain dopaminergic cells.

Authors:  Ada Ledonne; Mauro Federici; Michela Giustizieri; Mauro Pessia; Paola Imbrici; Mark J Millan; Giorgio Bernardi; Nicola B Mercuri
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

5.  A direct interaction between the sigma-1 receptor and the hERG voltage-gated K+ channel revealed by atomic force microscopy and homogeneous time-resolved fluorescence (HTRF®).

Authors:  Dilshan Balasuriya; Lauren D'Sa; Ronel Talker; Elodie Dupuis; Fabrice Maurin; Patrick Martin; Franck Borgese; Olivier Soriani; J Michael Edwardson
Journal:  J Biol Chem       Date:  2014-09-29       Impact factor: 5.157

6.  In vitro evaluation of guanidine analogs as sigma receptor ligands for potential anti-stroke therapeutics.

Authors:  Adam A Behensky; Michelle Cortes-Salva; Michael J Seminerio; Rae R Matsumoto; Jon C Antilla; Javier Cuevas
Journal:  J Pharmacol Exp Ther       Date:  2012-10-12       Impact factor: 4.030

7.  The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator.

Authors:  Dominique Fontanilla; Molly Johannessen; Abdol R Hajipour; Nicholas V Cozzi; Meyer B Jackson; Arnold E Ruoho
Journal:  Science       Date:  2009-02-13       Impact factor: 47.728

8.  Voltage-gated sodium channel modulation by sigma-receptors in cardiac myocytes and heterologous systems.

Authors:  Molly Johannessen; Subramaniam Ramachandran; Logan Riemer; Andrea Ramos-Serrano; Arnold E Ruoho; Meyer B Jackson
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-11       Impact factor: 4.249

9.  Pharmacology and therapeutic potential of sigma(1) receptor ligands.

Authors:  E J Cobos; J M Entrena; F R Nieto; C M Cendán; E Del Pozo
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

Review 10.  Small-animal SPECT and SPECT/CT: application in cardiovascular research.

Authors:  Reza Golestani; Chao Wu; René A Tio; Clark J Zeebregts; Artiom D Petrov; Freek J Beekman; Rudi A J O Dierckx; Hendrikus H Boersma; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-13       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.